|
 |
| |
| Licensing & Royalties |
|
| |
|
Licensing Opportunities
Technology Abstracts
|
Devices/Instrumentation- Other:
| Date | Ref. No. | Patent No. | Title |
|---|
| 1/09 | E-234-2008
|
| Method for Predicting and Detecting Tumor Metastasis | | 1/09 | E-295-2008
|
| Novel Inhibitor of NF-kappa B Pathway | | 12/08 |
| 6,993,959
| AFMAnalyze: Software Automation and Analysis of Atomic Force Microscopy (AFM) Data | | 12/08 | E-007-2008
|
| Method of Promoting Hematopoietic Stem Cell Engraftment by Enhancement of CXCR4 Activity | | 12/08 | E-345-2008
|
| Doxycycline-Inducible B16 Melanoma Cell Lines Expressing CXCR4 or CCR10 | | 12/08 | E-228-2002
|
| Methods and Compositions for Selectively Enriching Microbes | | 11/08 | E-256-1999
|
| Methods for Accurately Measuring and Regulating Bound Adrenomedullin | | 11/08 | E-023-2006
|
| Predictive Test for Age-Related Macular Degeneration in Asymptomatic Individuals | | 11/08 | E-174-2005
|
| Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identification | | 11/08 | E-223-2006
|
| Small-Molecule Modulators of the Thyroid-Stimulating Hormone (TSH) Receptor | | 11/08 | E-145-2008
|
| Compositions and Methods for Inhibition of Fat-Specific Protein 27 | | 11/08 | E-088-2006
|
| Ectopic Thymidylate Synthase Accelerates the Development of Hyperplastic Foci and Adenomas in Pancreatic Islets | | 11/08 | E-256-2007
|
| Radiation Induced and Targeted Chemotherapy | | 11/08 | E-144-2008
|
| System for Correction of MRI Head Motion | | 10/08 | E-204-2007
|
| Methods of Glycosylation and Bioconjugation | | 10/08 | E-240-2007
|
| Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV | | 10/08 | E-183-2005
|
| Methods for Conjugation of Oligosaccharides or Polysaccharides to Protein Carriers Through Oxime Linkages Via 3-Deoxy-D-Manno-Octulsonic Acid | | 10/08 | E-152-2004
|
| Use of Suppressive Oligonucleotides to Treat Uveitis | | 10/08 | E-280-2007
|
| Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use | | 10/08 | E-085-2005
|
| Methods for Preparing Complex Multivalent Immunogenic Conjugates | | 10/08 | E-090-2008
E-090-2008
|
| A Simple Genetic Test for Kidney Disease | | 10/08 | E-063-2008
|
| Nanoparticles for Imaging and Treatment of Brain Tumors | | 10/08 | E-242-2007
E-328-2001
|
| Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth | | 10/08 | E-279-2007
|
| Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use | | 10/08 | E-183-2002
|
| Method of Treating Infectious and Inflammatory Lung Disease with Suppressive Oligonucleotides | | 10/08 | E-153-2002
|
| Method of Treating and Preventing Infections in Immunocompromised Subjects with Immunostimulatory CpG Oligonucleotides | | 10/08 | E-210-2001
|
| Vaccine for Protection Against Shigella sonnei Disease | | 10/08 | E-230-2002
|
| Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use | | 9/08 | E-023-2002
|
| Methods for Preparing Bacillus anthracis Protective Antigen for Use in Vaccines | | 9/08 |
| 7,419,817
| Scalable Purification of AAV2, AAV4 or AAV5 Using Ion-Exchange Chromatography | | 9/08 | E-016-2008
|
| Modified Sugar Substrates and Methods of Use | | 9/08 | E-153-2005
E-153-2005
|
| Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin | | 9/08 | E-053-2008
|
| Aerosolized Vaccines | | 9/08 | E-109-2007
|
| A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen) | | 9/08 | E-021-2007
|
| Automated Method for Rapid Detection of Sickle Cell Disease Inhibitors | | 9/08 | E-147-2008
|
| Cyclized NGR Peptide for Tumor Targeting | | 9/08 | E-209-2007
|
| Active Guidewire Visualization Device and System for MRI Guided Intervention | | 9/08 | E-081-2008
|
| Microfabricated Particles Useful as MRI Contrast Agents | | 9/08 |
| 7,261,900
| Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines | | 9/08 | E-163-2007
|
| Bifunctional Compounds that Bind to Hormone Receptors | | 9/08 | E-323-2008
|
| Matriptase Hypomorphic Mouse Model of a Human Ichthyosis | | 9/08 | E-149-2006
|
| Compositions and Methods for Increasing Recombinant Protein Yields through the Modification of Cellular Properties | | 8/08 | E-332-2007
|
| Small Molecule Inhibitors of c-Met | | 8/08 | E-100-2007
|
| Quantitative Immunoassays for Measurement of Topoisomerase I as a Pharmacodynamic Marker for the Effect of Anti-Cancer Drugs | | 8/08 | E-325-2007
|
| Botulinum Toxoid | | 8/08 | E-155-2008
|
| Radiotracers for Imaging Cannabinoid Sub-Type1 (CB1) Receptor | | 8/08 | E-108-2008
|
| Fluorescent Cell Lines for Detection of DNA Damage | | 8/08 | E-175-2008
|
| Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors | | 8/08 | E-274-2003
|
| 2-Amino-O4-Substituted Pteridines: Improved Chemotherapy Adjuvants | | 8/08 | E-249-2005
|
| Methods of Treating and Preventing Renal Cancer using a Dimethane Sulfonate Compound | | 8/08 | E-141-2003
|
| Monoclonal Antibodies to HIV-1 Vpr | | 7/08 | E-070-2008
|
| Metabolic Biomarkers Indicate Exposure to Gamma Radiation | | 7/08 | E-261-2007
|
| Mouse Embryonic Stem Cell-based Functional Assay to Evaluate Mutations in BRCA2 | | 7/08 | E-233-2007
|
| Tendon Stem Cells | | 7/08 | E-218-2007
E-218-2007
|
| A2 Adenosine Receptor Agonists | | 7/08 | E-229-2006
|
| Novel O-GLcNAcase Inhibitor and Fluorogenic Substrate as a Tool for Diagnosing Type 2 Diabetes | | 7/08 | E-154-2006
|
| Use of Human Gamma Satellite Insulator Sequences to Prevent Gene Silencing and Allow for Long Term Expression of Integrated Transgenes | | 7/08 | E-091-2008
|
| Method for Detection and Quantification of PLK1 Expression and Activity | | 7/08 | E-321-2006
|
| Treatment of Skin Conditions Using DKK1 | | 7/08 | E-130-2007
E-130-2007
E-130-2007
|
| Steroid Derivatives as Inhibitors of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) | | 6/08 | E-298-2007
|
| Immunostimulatory Combinations of TLR Ligands and Methods of Use | | 6/08 | E-309-2006
E-309-2006
E-309-2006
|
| Cell-Nanofiber Composite and Cell-Nanofiber Composite Amalgam Based Engineered Intervertebral Disc | | 6/08 | E-317-2007
|
| Novel Fluorinated Dmt-Tic Analogues for Use as PET Radiotracers | | 6/08 | E-106-2007
|
| Use of Amyloid Proteins as Vaccine Scaffolds | | 6/08 | E-137-2004
|
| A Sensitive, High Throughput Pseudovirus-Based Papillomavirus Neutralization Assay for HPV 16 and HPV 18 | | 6/08 | E-042-2005
|
| Bioreactor Device and Method and System for Fabricating Tissue | | 5/08 | E-009-2008
|
| New Insect SF-9ET Cell Line for Determining Baculovirus Titers | | 5/08 | E-129-2008
|
| Synthetic Analogs of Juxtamembrane Domain of IGF-1 Receptor as Anti-Cancer Agents | | 4/08 | E-259-2007
|
| Nitrite and Nitrite-Methemoglobin Therapy to Detoxify Stroma-Free Hemoglobin Based Blood Substitutes | | 3/08 | E-100-2008
|
| Cell Line PE, Developed From Mouse Skin Tumors, Demonstrates Unique Qualities | | 3/08 | E-217-2007
|
| N-Acetyl Mannosamine as a Therapeutic Agent | | 3/08 | E-064-2008
|
| Epoxy-guaiane Cancer Inhibitors: New Class of Natural Products Isolated from the African Plant Phyllanthus englerii | | 3/08 | E-154-2007
|
| VEGF-B as a Therapeutic Agent for Neurodegenerative Disease | | 3/08 | E-223-1998
|
| P53 and VGEF Regulate Tumor Growth of NO2 Expressing Cancer Cells | | 3/08 | E-297-2007
|
| Novel Adjuvant Therapy Using TIMP-2 Variants | | 2/08 | E-137-2006
|
| Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Doxorubicin Cancer Therapy | | 2/08 | E-315-2007
|
| New Inhibitors of Multidrug Resistant Proteins Such As ABCG2 | | 2/08 | E-019-2005
|
| Synergistic Effect of TGF-beta Blockade and Immunogenic Agents on Tumors | | 2/08 | E-220-2003
|
| A New Technology for Identification of Genes Expressed in Hypoxia Conditions | | 2/08 | E-186-2007
|
| Papilloma Pseudovirus for Detection and Therapy of Tumors | | 2/08 | E-017-2008
|
| A Pharmacophore for Isatin-beta-Thiosemicarbazone Compounds with MDR1-Inverse Activity | | 2/08 | E-208-2007
|
| Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers | | 1/08 | E-008-2008
|
| Diagnosis and Treatment of Barrett's Esophagus and Associated Esophageal Adenocarcinoma | | 1/08 | E-241-2006
|
| A Drug Index to Quantify Harmful Drug Exposure in Older Adults | | 1/08 | E-108-2007
|
| Photosensitization by Nuclear Receptor-Ligand Complexes and Cell Ablation Uses Thereof | | 1/08 | E-147-1999
|
| Oligodeoxynucleotide and Its Use To Induce an Immune Response | | 12/07 | E-194-2007
|
| Tri-functional Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging | | 12/07 | E-157-2007
|
| Nanoparticles For Imaging: Targeted Nanoparticles That Can Be Imaged Through Magnetic Resonance, Optical, And Radioisotope Imaging | | 12/07 | E-005-2007
|
| Establishment of Two Cell Lines that Stably Express Luciferase for In Vivo Tracking | | 11/07 | E-302-2007
|
| A Family of Small Molecules for Selective Inhibition of Wip1 Phosphatase | | 11/07 | E-146-2007
|
| Selenocysteine Mediated Hybrid Antibody Molecules | | 10/07 | E-064-2005
|
| Biomarkers for Tissue Status | | 10/07 | E-114-2007
|
| Optical Slice Motion Tracker | | 10/07 | E-068-2007
|
| Novel Roles of a DNA Repair Protein, DNA-PKcs, in Obesity, Neurological Function, and Aging | | 9/07 | E-200-2007
|
| New and Improved Chemotherapy Adjuvants: Folate Based Inactivators of O6-alkylguanine-DNA alkyltransferase (alkyltransferase) | | 9/07 | E-308-2007
|
| A Transgenic Mouse Expressing Reverse Tetracycline-Controlled Transactivator in Melanocytes | | 9/07 | E-161-2007
|
| Treatment of Primary Tumors and Tumor Metastases with TNF-alpha Antagonists | | 9/07 | E-050-2007
|
| Methods of Determining the Prognosis of Hepatocellular Carcinoma | | 9/07 | E-319-2006
|
| Mutant Alleles of Hsp90 that Modulate the Lifespan of Yeast | | 9/07 |
| 6,790,948
7,431,926
| Tumor Suppressor Genes | | 9/07 |
| 7,256,256
| Peptide Inhibitor of Cyclin Dependent Kinase 4 (CDK4) Derived from MyoD | | 8/07 |
| 6,939,547
7,108,981
7,235,365 | Specific Binding Agents for KSHV vIL-6 that Neutralize a Biological Activity | | 8/07 | E-080-2006
|
| A New Series of Thalidomide Analogs That Have Potent Anti-Angiogenic Properties | | 8/07 | E-233-2006
E-233-2006
E-233-2006
|
| Design of Multi-functional RNA Nanoparticles and Nanotubes | | 8/07 | E-249-2006
E-249-2006
E-249-2006
|
| Device and Method for Protecting Against Coronary Artery Compression During Transcatheter Mitral Valve Annuloplasty | | 8/07 | E-122-2007
|
| An Improved Chromosomal Comparative Genomic Hybridization (CGH) Microarray for the Detection of Cancer Associated Genome Amplification and Deletion Events | | 8/07 |
| 6,685,933
7,235,232
| Interferon Alpha Hybrids | | 7/07 | E-258-2007
|
| Mice Genetically Deficient in the Chemoattractant Receptor FPR (formyl peptide receptor) | | 7/07 | E-025-2007
|
| Cytochrome P450 Inhibitors for Treatment of Cocaine-Induced Fetal Brain Injury | | 7/07 | E-288-2006
|
| Cyclic Phosphopeptide Inhibitors of Protein Phosphatase 2C Delta, Wip1 | | 7/07 | E-089-2005
|
| Benztropinamine Analogs as Dopamine Transport Inhibitors | | 6/07 |
| 5,554,603
| Orally Active Derivatives of 1,3,5(10)-estratriene | | 6/07 | E-121-2007
E-121-2007
|
| A Novel Discriminatory Small Peptide Inhibitor of Hsp90 Targeting Oncogenic Kinases | | 6/07 | E-098-2007
|
| Synthetic Macrolides Inhibit Breast Cancer Migration | | 6/07 | E-189-2006
|
| Method for the Direct Detection and Quantitation of Asparagine Synthetase in Biological Samples | | 6/07 | E-142-2007
|
| A MicroRNA Profile for Androgen Responsive Prostate Cancer | | 6/07 | E-088-2007
|
| Zscan4: A Gene Critical for Early Embryonic Development | | 5/07 | E-070-2005
|
| Inhibitors of Ubiquitin E1 | | 5/07 | E-256-2006
|
| Self-Assembling Nanoparticles Composed of Transmembrane Peptides and Their Application for Specific Intra-Tumor Delivery of Anti-Cancer Drugs | | 5/07 | E-133-2006
E-133-2006
|
| New Compounds and Methods for the Treatment of Spinal Muscular Atrophy and Other Diseases | | 5/07 |
| 7,192,705
7,116,433
| TMC1, a Deafness-Related Gene | | 5/07 | E-019-2000
E-019-2000
E-019-2000
|
| Inhibition of ABC Transporters by Transmembrane Domain Analogs | | 5/07 | E-056-2004
|
| STAMP, A Novel Cofactor and Possible Steroid Sparing Agent, Modulates Steroid-induced Induction or Repression of Steroid Receptors | | 5/07 | E-110-2004
|
| New Maleiimide Anti-Phosphatase Inhibitors | | 5/07 | E-307-2004
|
| Aminoalkyl Substituted O6-Benzylguanine Derivatives as Inactivators of O6-Alkylguanine-DNA Alkyltransferase and Adjuvants for Chemotherapy | | 4/07 | E-098-2006
|
| Structure of TIM Family Members | | 4/07 | E-141-2007
|
| High-level Expression and Purification of Untagged and Histidine-tagged Human Immunodeficiency Virus type-1 (HIV-1) Reverse Transcriptase | | 4/07 | E-272-2005
|
| Dissection Tools and Methods of Use | | 3/07 | E-172-2005
|
| Methods of Treating Conditions Characterized by Unwanted or Excessive Presynaptic Neuronal Activity or Secretion | | 3/07 | B-019-1999
|
| Serotonin-Deficient Knock-out Mouse | | 3/07 | E-311-2004
|
| Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis | | 3/07 | E-024-2006
|
| Microdialysis Probe for Accessing Tissue in-vivo | | 3/07 | E-105-2003
|
| Cloning and Characterization of an Avian Adeno-Associated Virus and Uses Thereof | | 2/07 | E-317-2004
|
| Metal Chelators and Target-Moiety Complexes for Imaging | | 2/07 | E-267-2006
|
| A Novel Combination of CXCR-4 Antagonist T22 with Conventional Immunotherapy Improves Treatment Efficacy in Established Tumors | | 2/07 | E-070-2007
|
| Human Cancer Therapy Using Engineered Anthrax Lethal Toxin | | 2/07 | E-138-2006
|
| Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed Cells | | 1/07 |
| 5,616,471
| Methods for Assaying Hair Follicle Growth and Development | | 1/07 | E-305-2006
|
| Macrocyclic Grb2 SH2 Domain-Binding Inhibitors: New Anti-cancer and Anti-angiogenic Therapeutic Agents | | 1/07 | E-234-2005
E-234-2005
|
| Novel Benztropine Analogs for Treatment of Cocaine Abuse and Other Mental Disorders | | 12/06 | E-014-2007
|
| Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents | | 12/06 | E-033-2007
|
| Production, Recovery and Purification Process for Plasmid DNA Clinical Manufacturing | | 12/06 | E-046-2006
|
| Small Molecules for Imaging Protein-Protein Interactions | | 12/06 | E-268-2005
|
| Methods and Systems for Identifying and Classifying Drug Targets | | 12/06 | E-347-2004
|
| ARH3, a Therapeutic Target for Cancer, Ischemia, and Inflammation | | 12/06 | E-143-2000
|
| Sample Delivery System with Laminar Mixing for Microvolume Biosensing | | 12/06 | E-261-2003
|
| Gene Cassette for Enhancement of Protein Production | | 12/06 | E-295-2005
|
| Novel Treatments for Autoimmune Neuroinflammatory Diseases including Multiple Sclerosis | | 11/06 | E-186-2006
|
| Second Generation Nitric Oxide-releasing Non-steroidal Anti-inflammatory Drugs Possessing a Diazeniumdiolate Group (NONO-NSAIDs) | | 9/06 | E-271-2005
|
| Novel Treatment of Vascular Cognitive Impairment | | 9/06 | E-218-2006
|
| Ghost Native-PAGE with Colorless Compound Derived from Coomassie Brilliant Blue | | 09/06 | E-186-2005
|
| Human Protein Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Derived Anti-Angiogenic Peptides | | 8/06 | E-015-2006
|
| Hollow Waveguide Laser Delivery System for Digital Particle Image Velocity | | 8/06 | E-201-2006
|
| Diagnostic and Therapeutic Strategies for Metastatic Hepatocellular Carcinoma by Targeting Osteopontin | | 8/06 | E-042-2006
|
| Complement Regulatory Gene Variants as Predictive Tests for Age-related Macular Degeneration (AMD) | | 8/06 |
|
| Use of Grape Skin Extracts as Anti-Cancer Agents | | 8/06 | E-255-2006
|
| Target-Specific Activatable Optical Probes for In Vivo Imaging | | 7/06 | E-136-2006
|
| Method for Expanding Allodepleted Antigen Specific T Cells | | 7/06 | E-244-2005
|
| On-Demand Protein Microarrays: In Vitro Assembly of Protein Microarrays | | 6/06 | E-165-2006
|
| Diamidine Inhibitors of Tdp1 as Anti-Cancer Agents | | 6/06 | E-097-2006
|
| Use of Tetracyclines as Anti-Cancer Agents | | 6/06 | E-122-2006
|
| Agonist Epitopes for Renal Cell Carcinoma | | 6/06 | E-108-2005
|
| Treatment of Inflammatory Bowel Disease (IBD) using NF-KB Decoy Polynucleotides | | 6/06 | E-003-2005
|
| Treatment and Prevention of Inflammatory Bowel Disease (IBD) using Mutant and Chimeric IL-13 Molecules | | 6/06 | E-091-2004
|
| Ultrasonic Waves with Nanovessels or Tethered Nanotube/Monoclonal Antibody Composites for Cancer Therapy | | 6/06 | E-012-2006
|
| Ear Hole Cutter for Animal Identification and Tissue Sampling | | 6/06 | E-156-2006
|
| Beta-Amyloid PET Imaging Agents | | 6/06 | E-282-2003
|
| Method Evolved for Recognition of Thrombophilia (MERT): Clinical Predictive Genetic Test for Venous Thrombosis | | 5/06 | E-075-2003
|
| Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof | | 5/06 | E-196-2004
|
| Bone Morphogenetic Variants, Compositions and Methods of Treatment | | 5/06 | E-094-2006
|
| Preparation of a Peptide Targeted Human RNase, RGD-Eosinophil Derived Neurotoxin (RGD-EDN) To Specifically Target Tumor Vasculature | | 5/06 | E-057-2005
|
| Novel Glycated Peptides and Proteins as Biomarkers for Diabetes Control | | 5/06 |
| 5,706,520
| Hand Puncture Protector for Nurses
| | 4/06 | |
| Novel Methods and Compositions for Diagnosing AIDS and Other Diseases Involving Immune System Activation | | 3/06 | E-181-2005
|
| Impaired Neuregulin1-stimulated B Lymphoblast Migration as Diagnostic for Schizophrenia | | 3/06 | E-262-1999
|
| Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer | | 3/06 | E-243-2005
|
| Susceptibility-Matched Multiwell Plates for High-Throughput Screening by Magnetic Resonance Imaging and Spectroscopy | | 3/06 | E-319-2005
|
| Methods of Treating Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents | | 3/06 | E-258-2005
|
| Method for Determining Redox Status of a Tissue | | 3/06 | E-309-2005
|
| Use of Replicators in Gene Therapy | | 3/06 | E-207-2005
|
| Measuring Fifteen Endogenous Estrogens Simultaneously in Human Urine by High-Performance Liquid Chromatography-Mass Spectrometry | | 3/06 |
| 6,391,642
| Transformation-Associated Recombination (TAR) Cloning | | 3/06 | E-254-2003
|
| Treatment of Pulmonary Hypertension (PH) Using Nitrite Therapy | | 2/06 | E-099-2005
|
| Human Sweet and Umami Taste Receptor Variants | | 2/06 | E-296-2004
|
| Novel Form of Interleukin-15, Fc-IL-15, and Methods of Use | | 2/06 | E-106-2005
|
| Identification of Biomarkers by Serum Protein Profiling | | 2/06 | E-222-2003
|
| Haplotypes of Human Bitter Taste Receptor Genes | | 2/06 |
| 6,426,198
7,045,675
| Genes For Niemann-Pick Type C Disease | | 1/06 | E-163-2005
|
| Intraperitoneal Injection of Pseudovirions Carrying a Toxin Leads to Significantly Reduced Tumor Size | | 1/06 | E-166-2005
|
| Hydropneumatic Fluid Control for a Cell Culturing System | | 12/05 | E-058-2005
|
| Synthesis of Indenoisoquinoliniums and Methods of Use | | 12/05 | E-142-2005
|
| A Single Ribozyme to Catalyze both Trimming and Transacting Catalysis - Potential Therapeutic for HPV Infection and Cervical Cancer | | 12/05 | E-039-2005
|
| Confocal Fiber-Optic Laser Method for Intraocular Lens Power Measurement | | 12/05 | E-145-2005
|
| Tri-Functional Nanospheres | | 12/05 | E-205-1999
|
| Bisubstrate Inhibitors of Acetyltransferases | | 12/05 | E-210-2005
|
| Mitotic Spindle ASPM as a Diagnostic Marker for Neoplasia and Uses Thereof | | 11/05 | E-272-2002
E-272-2002
|
| Serine Protease Inhibitors | | 10/05 | E-081-2001
E-081-2001
E-081-2001
|
| Zebularine, A Stable and Orally Active Inhibitor of Cytosine DNA Methyltransferase Capable of Reactivating Dormant Tumor Suppressor and Inhibiting Tumor Growth | | 10/05 | E-065-2005
|
| Novobiocin Analogues as Anticancer Agents | | 10/05 |
| 5,272,146
5,441,941
| 1,2-Dihydroellipticines with Activity Against CNS-Specific Cancer Cell Lines | | 9/05 |
| 5,217,953
5,565,424
6,630,124 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists | | 9/05 | E-129-2005
|
| Miniature Laser-Induced Fluorescence Detector | | 9/05 | E-327-2004
|
| A New Approach Toward Macrocyclization of Peptides | | 9/05 | E-124-2004
E-124-2004
E-124-2004
|
| Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions | | 9/05 |
| 6,136,992
| Novel 2-Alkoxy Estradiols and Derivatives Thereof | | 9/05 | E-315-2003
|
| SH2 Domain Binding Inhibitors (E-315-2003) | | 9/05 | E-060-2002
|
| DNA-Binding Polyamide Drug Conjugates | | 8/05 | E-318-2000
|
| Method for Determining Sensitivity to a Bacteriophage | | 8/05 | E-075-2001
|
| Methods and Compositions for Production and Purification of Recombinant Staphylococcal Enterotoxin B (rSEB) | | 8/05 |
| 5,861,156
| Methods of Delivering Agents to Target Cells | | 8/05 | E-235-2004
|
| Inhibition of SMAD-Signaling Leads to Enhanced Insulin Production and Better Glucose Control: A Potential Therapy for Diabetes and Associated Complications Due to Hyperglycemia | | 8/05 | E-092-2004
|
| Anti-Marinobufagenin Antibodies and Methods for Their Use | | 8/05 | E-140-2005
|
| Induction of C/EBPalpha and Uses Thereof | | 8/05 |
E-131-2000
|
| Methods for Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity | | 8/05 |
| 6,413,544
6,770,291
7,001,614 | Novel DNA Liposome Complexes for Increased Systemic Delivery and Gene Expression | | 7/05 | E-147-2005
|
| Standardizing Criteria on Cancer Biomarkers as Foundation of a Database: Creating a Common Language (Data Elements) for Cancer Biomarkers Tracking and Utilization for Professionals in Oncology Research | | 7/05 | E-033-2004
|
| Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof | | 7/05 | E-018-2003
|
| Postnatal Stem Cells and Uses Thereof | | 6/05 | E-121-2004
|
| A New Antiviral Pathway that is Responsible for Viral Clearance: Modulation of ADAR1 Activities Enhance Antiviral Therapies and Virus Infection of Tissue Culture Systems | | 6/05 | E-354-2004
|
| Proteomic Profiles Associated with Aging | | 6/05 | E-188-2004
|
| Therapeutic Delivery of Nitric Oxide From Novel Diazeniumdiolated Derivatives of Acrylonitrile-based Polymers | | 5/05 | E-199-1999
|
| Mycolactone and Related Compounds | | 5/05 | E-245-2004
|
| Methods of Reducing the Activity and Concentration of an Eph Receptor Tyrosine Kinase | | 5/05 | E-272-2003
|
| Analogs of Thalidomide as Potential Angiogenesis Inhibitors | | 4/05 | E-176-2003
|
| Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria | | 4/05 | E-343-2004
|
| Use of Targeted Bone Marrow Cell Infiltration to Induce Pigmentation and Hair Growth in Skin | | 4/05 | E-068-2005
|
| Identification of Molecular Markers for Endometriosis in Blood Lymphocytes Using DNA Microarrays | | 4/05 | E-333-2004
|
| HIV Neutralization by Structure-Based Enhancements of CD4-Molecular Mimicry | | 4/05 |
| 5,104,977
5,656,587
5,705,477 | Compositions of Transforming Growth Factor Beta (TGF-beta) Which Promotes Wound Healing and Methods for Their Use | | 3/05 | E-001-2005
|
| Carbohydrate-Encapsulated Gold Nanoparticles as Novel Anti-Metastatic Agents | | 3/05 | E-079-2005
|
| Inhibition of Human Papillomavirus Type 16 and 18 E6 and E7 Oncogene Expression by E6 and E7-specific siRNAs | | 3/05 | E-037-2005
|
| Dimer Inhibitory Peptides of CXCR4 as a Possible Novel Therapy for Cancer | | 3/05 | E-354-2004
|
| Biomarkers for Osteoarthritis | | 3/05 |
| 4,942,184
| Water-Soluble, Antineoplastic Derivatives of Taxol | | 3/05 | E-101-2005
|
| Karyotypic Complexity as a Determinant of Anti-Cancer Drug Activity | | 2/05 | E-166-2004
E-166-2004
E-166-2004
|
| Novel Thermostable Y-Family DNA Polymerases | | 2/05 | E-103-2004
E-103-2004
|
| Expression Tags for High Yield Soluble Expression of Recombinant Proteins | | 2/05 | E-094-2003
|
| A Novel, Preservative-Free Steroid Formulation for Use as an Anti-Inflammatory | | 2/05 |
| 6,727,405
| The Whey Acidic Protein (WAP) Promoter and Its Use to Express Therapeutic Proteins in the Milk of Transgenic Mammals | | 2/05 | E-248-2004
|
| A3 Adenosine Receptor Agonists | | 1/05 | E-244-2004
|
| The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof | | 1/05 | E-131-2002
|
| A Method of Treating Inflammatory Bowel Disease (IBD) | | 1/05 | E-123-2001
E-124-2001
|
| Peptide Agonists of Prostate-Specific Antigen and Uses Thereof | | 1/05 | E-032-2004
|
| Use of Anti-Parafibromin Antibodies to Diagnose Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT) and Parathyroid Cancer | | 1/05 | E-259-2003
|
| Anti-Proliferative Activity of an Unexpected mTOR Kinase Inhibitor | | 12/04 | E-095-2004
|
| Novel Compounds That Release Both Nitric Oxide (NO) and Nitroxyl (HNO) As Pharmacological Agents | | 12/04 | E-291-2004
|
| Intracellular Contrast Agents for Magnetic Resonance Imaging | | 12/04 | E-004-2005
|
| Human Monoclonal Antibodies Against Hendra and Nipah Viruses | | 12/04 |
| 7,238,473
| TTP as a Regulator of GM-CSF mRNA Deadenylation and Stability | | 11/04 | E-233-2004
E-233-2004
|
| Anti-HIV Peptide Secreting Bacteria: Therapeutics and Methods of Use | | 10/04 | E-306-2003
|
| Genetic Fingerprint of Acute Stroke | | 10/04 | E-277-2004
|
| Chromatography Apparatus and Method | | 10/04 |
| 7,014,816
| Food Quality Indicator Device | | 10/04 | E-062-2003
|
| Use of Smad3 Inhibitor in the Treatment of Fibrosis Dependent on Epithelial to Mesenchymal Transition as in the Eye and Kidney | | 8/04 | E-056-2003
E-056-2003
|
| Human Neuronal Cells for Therapeutic Uses | | 8/04 | E-093-2004
|
| Compositions of Matter and Methods of Use of Fluorescent Protein Kinases | | 8/04 | E-094-2004
|
| Pharmacodynamic Assay | | 8/04 | E-127-2003
|
| Multivariate Profiling of Complex Biological Regulatory Pathways | | 8/04 | E-254-2003
|
| Methods of Use of Nitrite Therapy | | 8/04 | E-074-2004
|
| Methylation Inhibitor Compounds | | 7/04 | E-090-2003
|
| Vaccine Peptide Derived from XAGE-1 to Prevent Tumor Growth | | 6/04 | E-044-2004
|
| Antibody (Anti-Allergen) Microarray | | 6/04 | E-165-2004
|
| SARS Coronavirus MVA Vaccines and Therapy | | 6/04 | E-278-2003
|
| Interferon-Alpha SARS Treatment | | 5/04 | E-040-2004
|
| Methods for Producing Biliverdin | | 4/04 | E-142-2002
|
| Reagents to Produce Purified Human 14-3-3 Zeta and 14-3-3 Epsilon as Glutathione-S-Transferase Fusion Protein | | 4/04 | E-326-2002
|
| Triplex Hairpin Ribozyme | | 4/04 |
| 6,676,657
| Endoluminal Radiofrequency Cauterization System | | 3/04 |
| 6,699,842
| Dominant Negative Deletion Mutants Of C-Jun And Their Use In The Prevention And Treatment Of Cancer | | 3/04 | E-277-2003
|
| Stimulation or Inhibition of Gamma Delta T-Cells to Promote or Inhibit Bone Growth | | 3/04 | E-231-2002
|
| Deazaflavin Compounds and Methods of Use Thereof | | 3/04 | E-109-2004
|
| Cell-Based Assay of I-kappaB Kinase Activity | | 3/04 | E-338-2003
|
| Methods for Imaging the Lymphatic System Using Dendrimer-Based Contrast Agents | | 3/04 | E-218-2003
E-218-2003
|
| Method and Apparatus for Bioweapon Decontamination | | 2/04 | E-244-2002
|
| Glioma-Selective Polypeptides, Alone or Coupled to a Therapeutic/Diagnostic Agent, Compositions Comprising Same, and Uses Thereof | | 2/04 |
| 5,460,941
5,510,473
5,707,811 | Homologous DNA Recombination | | 2/04 | E-049-2003
|
| UltraRad � A Method and Probe to Enhance Radiation Delivery | | 2/04 | E-077-2002
|
| Computer-Aided Classification of Anomalies in Anatomical Structures | | 2/04 | E-227-2001
|
| Brother of the Regulator of Imprinted Sites (BORIS) | | 2/04 | E-091-2003
|
| Methods for the Treatment of Parkinson's Disease and Other alpha-synucleinopathies | | 1/04 |
| 5,525,711
5,612,468
6,451,530 | Fluorescent Pteridine Nucleoside Analogs | | 1/04 | E-039-2003
|
| Combinatorial Therapy for Protein Signaling Diseases | | 1/04 | E-309-2003
|
| A Simple Method and Apparatus to Produce a Closed, Transverse Bone Fracture in a Mouse or Other Skeletal Creature | | 1/04 |
| 6,211,149
6,355,610
| Inhibitors of Formation of Protease Resistant Prion Protein | | 12/03 |
| 5,998,149
6,406,860
| Method for Detecting Transmissible Spongiform Encephalopathies | | 12/03 | E-211-1998
E-211-1998
E-211-1998
|
| Methods for Detecting Cancer Cells | | 12/03 |
| 7,314,725
| Phenylthiocarbamide (PTC) Taste Receptor | | 12/03 | E-167-2003
|
| Method for Analysis of Biomarkers Concentrated with Biomarker Attractants | | 12/03 | E-276-2001
|
| Improved Endogenous Opioid Anti-Nociception with Reduced Neurodegeneration, Hyperalgesia, Allodynia and Tolerance | | 12/03 | E-109-2000
|
| Pain Control by the Selective Local Ablation of Nociceptive Neurons | | 12/03 | E-260-2002
|
| Methods for Assessing the Ability of HIV Patients to Restrict HIV Replication | | 11/03 | E-224-2003
|
| Inhibition of Retrovirus Gene Expression by PSF | | 11/03 |
| 6,875,855
| Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene | | 11/03 | E-083-2003
|
| Intracellular Trapping of Radionuclides by Enzyme-Mediated Reduction | | 8/03 | E-063-2003
|
| Rapamycin Resistant T Cells and Therapeutic Uses Thereof | | 8/03 | E-017-2003
|
| Pattern Recognition of Whole Cell Mass Spectra | | 8/03 | E-304-2003
|
| Venting and Drying of Samples in Multi-Well Plates | | 08/03 | E-171-2002
|
| Stem Cell Culture, Monitoring and Storage System | | 8/03 | E-079-2003
|
| Diffusion Tensor and q-Space MRI Specimen Characterization | | 8/03 | E-026-2003
|
| Method and System for Developing and Querying A Sequence Driven Contextual Knowledge Base | | 7/03 | E-041-2003
|
| HeadWave Clinical Coil Designed for Magnetic Resonance Elastography | | 7/03 | E-162-2000
|
| 3-D Video Image-Based Microscopic Robotic Targeting | | 5/03 | E-240-2002
|
| HTLV-1 Cell Binding and Inhibition | | 5/03 |
| 7,087,589
| Methanocarba Cycloalkyl Nucleoside Analogues | | 5/03 |
| 5,610,060
| Isolated Helicobacter hepaticus | | 5/03 | E-097-2003
|
| Triggering Receptors Expressed in Myeloid Cells (TREM) Like Transcript (TLT-1), A Novel Inhibitory Receptor of Platelets and Uses Therefore | | 5/03 | E-256-2002
|
| 17-AAG Treatment of Diseases Sensitive to c-KIT Down Regulation | | 4/03 | E-060-2000
E-060-2000
|
| sFRP and Peptide Motifs That Interact with sFRP and Methods of Their Use | | 4/03 | E-191-2002
|
| Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof | | 3/03 | E-209-02/0
|
| Method of Separating Recombinant Immunotoxin | | 11/02 | E-136-02/0
|
| Novel Molecular Conjugates for Signal Amplification | | 9/02 | E-048-2002
|
| Antiproliferative Actions of Human IGF Binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II | | 8/02 | E-053-02/0
|
| Methods and Compositions for the Promotion of Hair Growth Utilizing Actin-Binding Peptides | | 7/02 |
| 6,246,784
6,345,112
6,556,696 | Method for Segmenting Medical Images and Detecting Surface Anomalies in Anatomical Structures | | 7/02 |
| 6,756,399
| Use of Lipoxygenase Inhibitors and PPAR Ligands as Anti-Cancer Therapeutic and Intervention Agents | | 5/02 | E-151-01/0
|
| Method of Promoting Engraftment of a Donor Transplant in a Recipient Host | | 3/02 | E-328-2001
|
| Use of CpG Oligodeoxynucleotides to Encourage Angiogenesis | | 1/02 | E-295-1999
|
| Gene Involved in Dietary Sterol Absorption and Excretion and Uses Therefor | | 12/01 | E-209-2001
E-209-2001
E-209-2001
|
| Neurotrophic Components of the ADNF I Complex
| | 9/01 | E-067-2001
|
| Secretion of Native Recombinant Lysosomal Enzymes by Liver | | 08/01 | E-105-00/0
|
| Method to Fabricate Continuous Lengths of Helical Coiled Shape Memory Wire | | 8/01 | E-264-2001
|
| A Mouse Model of von Hippel-Lindau Disease | | 8/01 | E-243-2001
|
| A Mouse Model of Multiple Endocrine Neoplasia, Type I | | 6/01 | E-187-2001
|
| Structure Determination of Materials Using Electron Microscopy | | 4/01 |
| 7,351,580
| Use of Endogenous Vertebrate Phytase to Increase Capacity To Utilize Phytic Acid in Livestock Feed | | 4/01 |
| 5,861,158
| Immunization from an Immunized Allogeneic Bone Marrow Donor
| | 2/01 | E-001-2001
E-001-2001
|
| Coupled Calcium/Citrate Delivery System and Method for Apheresis Devices | | 2/01 | E-020-2001
|
| Plasmids Expressing START Domains of StAR and MLN64 | | 02/01 | E-170-99/0
|
| In Vivo DNA Engineering Using the Recombination System (red) of Bacteriophage Lambda | | 1/01 | 07/919,378
| 5,459,056
| Human T Cell Line Chronically Infected With HIV | | 12/00 | E-281-2000
|
| A Mouse Model of UV-Inducible Cutaneous Malignant Melanoma | | 12/00 |
| 6,521,635
| Inhibition of MXR Transport by Acridine Derivatives | | 12/00 | E-223-00/0
|
| Transcranial Magnetic Stimulation Coil for Specific Non-Invasive Deep Brain Stimulation | | 12/00 | 60/209,067
|
| Peroxynitrite Generators, Compositions Comprising Same, and Methods for Treating Biological Disorders Using Same | | 12/00 | E-185-2000
|
| Dombrock Blood Typing | | 12/00 | E-014-2000
|
| Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof | | 12/00 |
| 7,003,403
| Quantifying Gene Relatedness via Nonlinear Prediction of Gene Expression Levels | | 8/00 | E-277-98/0
|
| Delivery of Proteins Across Polar Epithelial Cell Layers | | 7/00 | E-087-2000
|
| Establishment of Cellular Manipulations Which Enhance Oligo-Mediated Gene Targeting
| | 9/99 |
| 6,057,346
| Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers | | 9/99 |
| 6,316,190
| Oligonucleotides Which Specifically Bind Retroviral Nucleocapsid Proteins | | 9/99 |
| 6,613,318
7,005,419
7,125,850 | Methods For Identifying Modulators Of GADD45 Polypeptide Activity | | 8/99 |
| 5,857,309
5,888,705
| Methods of Stimulating Proliferation and Differentiation of Human Pancreatic Cells Ex Vivo | | 7/99 | E-013-1999
|
| Magnetic Resonance Tracking of Magnetically Labeled Cells | | 6/99 |
| 5,650,627
| Sensitive Assay for Measuring Gallium Levels in Body Tissues and Fluids | | 5/99 |
| 6,221,620
| Monoclonal Antibodies Specific for Human Thymidylate Synthase | | 4/99 | E-216-1997
|
| Spectral Cloning - An Innovative Technical And Conceptual Approach To The Cloning And Characterization Of Every Chromosomal Aberration In Cancer Samples | | 3/99 | E-006-98/0
|
| Methods and Compositions for Reducing Ischemic Injury of the Heart by Administering Adenosine A3 and Adenosine A1 Receptor Agonists | | 3/99 | 08/813,787
|
| Methods and Compositions for Protecting Against Cardiac Ischemia by Administering Adenosine A2a Receptor Antagonists | | 3/99 |
| 5,645,988
| Method of Identifying and Using Drugs with Selective Effect Against Cancer Cells | | 2/99 | 60/105,945
09/428,832
|
| Fiber Optic Probe For Quantitative Optical Spectroscopy | | 2/99 |
| 6,867,180
| Use Of Calreticulin And Calreticulin Fragments To Inhibit Endothelial Cell Growth And Angiogenesis, And Suppress Tumor Growth | | 2/99 | E-193-1995
|
| Methods for Determining the Prognosis of Breast Cancer Using Antibodies Specific for Thymidylate Synthase | | 12/98 | E-032-96/1
|
| Infectious Papillomavirus Pseudoviral Particles | | 12/98 | E-066-1996
|
| AAV4 Vector And Uses Thereof | | 12/98 |
| 6,326,466
| Double-Stranded RNA Dependent Protein Kinase Derived Peptides To Promote Proliferation Of Cells And Tissues In A Controlled Manner | | 12/98 |
| 5,720,892
5,824,520
| Method of Inhibiting the Activity of an Intracellular Constituent | | 12/98 | E-285-1997
|
| A Display Technique for Identifying LINE-1 Insertion Site Polymorphisms | | 12/98 |
| 6,197,751
| Thymosin alpha 1 Promotes Tissue Repair, Angiogenesis and Cell Migration
| | 12/98 |
| 6,492,166
| Use of Constitutive Transport Elements to Control the Host Range of Retroviral Vectors
| | 9/98 | E-166-1998
|
| LIF And Related Cytokines That Operate Through The gp130 Receptor Pathway As A Means To Enhancing Embryo Implantation In Mammals And As An Alternative To Using Estrogen | | 9/98 | 60/094,246
|
| Protection Of Neural Cells From Catecholamine-Induced Apoptosis By
Macrophage Migration Inhibitory Factor (MIF)
| | 9/98 | E-078-1997
|
| Animal Model for Age-Related Macular Degeneration and Methods for Use Thereof | | 9/98 | E-174-1997
|
| Protection Of Tissue From Ischemic Damage | | 5/98 |
| 5,937,083
| Image Registration Using Closest Corresponding Voxels With An Iterative Registration Process | | 5/98 | E-170-97/0
|
| Molecular Computing Elements: Gates And Flip-Flops | | 5/98 | 60/056,452
09/136,136
|
| Methods And Apparatuses For Processing Synthesized Models Of Complex
Medical Structures
| | 4/98 |
| 7,041,441
| Phage Display Of Intact Domains At High Copy Number | | 1/98 | E-032-1997
|
| Method Of Promoting Tumor Necrosis Using MIG | | 1/98 |
| 5,914,121
| Formation Of Human Bone In Vivo | | 10/97 |
| 6,562,589
7,232,890
| AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer
| | 10/97 |
| 5,211,657
| Laminin A Peptides | | 5/97 |
| 6,884,871
6,924,367
7,049,291 | Isolation And Use Of Tissue Growth-Inducing FRZB Protein | | 1/97 |
| 6,780,413
| Immunotoxin (MAB-RICIN) For The Treatment Of Focal Movement Disorders | | 12/96 |
| 6,391,651
5,989,551
| Materials And Methods For Detection And Treatment Of Insulin Dependent Diabetes | | 11/96 | E-088-1996
|
| Point Mutated ras Peptides for the Generation of CD8+ Cytotoxic T Lymphocytes | | 11/96 |
| 5,939,530
| Inhibitory And Non-Inhibitory Antigen Binding Polypeptides Against Human P450 Enzymes | | 11/96 |
| 6,197,578
| Cells Expressing Both Human CD4 And A Human Fusion Accessory Factor Associated With HIV Infection | | 11/96 | 09/185,408
|
| Glycoprotein Hormone Superagonists | | 10/96 | 08/630,961
09/326,976
| 5,998,149
| A Method For Detecting Transmissible Spongiform Encephalopathies | | 9/96 | 06/481,934
| 4,565,789
| Cell Matrix Receptor System And Use In Cancer Diagnosis And Management | | 7/96 |
| 5,219,991
5,527,685
| Macrophage Stimulating Protein | | 7/96 |
| 5,352,772
| 75 Kilodalton Interleukin-2 Receptor Proteins And Their Use | | 7/96 |
| 5,853,697
| Methods Of Treating Established Colitis Using Antibodies Against IL-12 | | 7/96 |
| 6,319,687
| Pigment Epithelium Derived Factor: Characterization, Genomic Organization and Sequence of PEDF Gene | | 7/96 |
| 5,840,686
| Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein | | 7/96 | 08/789,096
| 6,017,721
| Chromatographic Method And Device For Preparing Blood Serum For Compatibility Testing | | 4/96 |
| 6,265,160
| Method Of Identifying Inhibitors Of The Jak-STAT Signal Transduction Pathway | | 4/96 |
| 5,716,788
5,763,216
| A Gene Encoding a Human Reduced Folate Carrier (RFC) and Methods for the Treatment of Methotrexate-Resistant, Transport-Deficient Cancer Cells | | 4/96 |
| 5,426,184
| Glycosides Of Cyclodextrin, And Processes For Their Preparation | | 2/96 | 08/083,945
07/827,043
|
| AAMP-1 | | 2/96 |
| 5,650,550
| Mutants Having a Deficit of Functional Steroid Hormone Receptors | | 12/95 | E-161-1995
E-222-1995
|
| cDNA Sequence of a Clone Encoding Arylalkylamine N-acetyltransferase
and
Human Gene Encoding Serotonin N-acetyltransferase
| | 5/95 | 08/133,574
08/319,888
08/814,228 |
5,650,442
5,837,736 | Nitric Oxide-Releasing Compounds As Hypoxic Cell Radiation Sensitizers | | 5/95 |
| 5,487,998
| Trapping of Aflatoxins and Phytoestrogens | | 4/94 |
| 5,569,602
| The First Immortalized Kaposi's Sarcoma Cell Line | | 1/94 |
| 5,437,951
5,756,284
5,709,996 | Self-Assembling Recombinant Papillomavirus Capsid Proteins | | 12/93 |
| 5,468,468
5,863,739
5,833,986 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors | | 11/93 |
| 5,518,880
5,912,173
| Methods for Diagnoses and Treatment of XSCID | | 2/92 |
| 5,301,671
5,520,182
| Two- and Three-Dimensional Autoradiographic Imaging Utilizing Charge Coupled Devices |
Back
|
|
|
|
| |
|
|
|